Free Newsletter
ED drugs slapped with new warning
Here's a trade-off that could have been dreamed up by a Puritan: Treat your ED, go deaf. The FDA is adding new warnings of sudden hearing loss to three of the popular ED drugs--you know their names. The agency doesn't have proof that the drugs caused sudden deafness but decided to add the warning after digging up 29 reports of the problem since 1996. The scary part, agency officials said, was that these patients lost their hearing--in one ear only--within two days of starting on the meds, sometimes within hours. In a third of the cases, the loss was temporary.
- read the FDA warning
- check out the report from the Associated Press
Related Articles:
Gene therapy approach may work against ED. Report
Safety concerns force delay for Phase III ED trial. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: